TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes

Blood

Volumn 119, Issue 5, 2012, Pages 1256-1262

  Girard, Thomas J ^a   Tuley, Elodee ^a   Broze, George J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; GLYCOSYLPHOSPHATIDYLINOSITOL; ISOPROTEIN; MESSENGER RNA; PHOSPHOLIPASE C; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE FACTOR PATHWAY INHIBITOR BETA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BLOOD CLOTTING; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOASSAY; MICROSOME; NEGATIVE FEEDBACK; NONHUMAN; PLACENTA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SECRETION;

EID: 84856604115     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-388512     Document Type: Article

References (30)

1. Broze GJ Jr, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry. 1990;29(33):7539-7546. (Pubitemid 20279168)
2. Wun T-C, Kretzmer KK, Girard TJ, Miletich JP, Broze, GJ Jr. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem. 1988;263(13):6001-6004.
3. Girard TJ, Warren LA, Novotny WF, et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature. 1989;338(6215):518-520. (Pubitemid 19107996)
4. Dahm AE, Sandset PM, Rosendaal FR. The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1. J Thromb Haemost. 2008;6(2):393-395.
5. Ndonwi M, Tuley EA, Broze GJ Jr. The Kunitz-3 domain of TFPIalpha is required for protein S-dependent enhancement of factor Xa inhibition. Blood. 2010;116(8):1344-1351.
6. Piro O, Broze GJ Jr. Comparison of cell-surface TFPIalpha and beta. J Thromb Haemost. 2005; 3(12):2677-2683.
7. Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis. Blood. 2003;101(11):4387-4392. (Pubitemid 36857803)
8. Lesnik P, Vonica A, Guerin M, Moreau M, Chapman MJ. Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a). Arterioscler Thromb. 1993;13(7):1066-1075. (Pubitemid 23195809)
9. Novotny WF, Girard TJ, Miletich JP, Broze GJ Jr. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood. 1988;72(6): 2020-2025. (Pubitemid 19030892)
10. Maroney SA, Haberichter SL, Friese P, et al. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood. 2007; 109(5):1931-1937. (Pubitemid 46348189)
11. Sandset PM, Abildgaard U, Larsen ML. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res. 1988;50(6):803-813.
12. Novotny WF, Brown SG, Miletich JP, Rader DJ, Broze, GJ Jr. Plasma antigen levels of the lipoprotein- associated coagulation inhibitor in patient samples. Blood. 1991;78(2):387-393.
13. Novotny WF, Palmier M, Wun T-C, Broze GJ Jr, Miletich JP. Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor. Blood. 1991;78(2):394-400.
14. Lupu C, Poulsen E, Roquefeuil S,Westmuckett AD, Kakkar VV, Lupu F. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture. Arterioscler Thromb Vasc Biol. 1999;19(9):2251-2262. (Pubitemid 29422260)
15. Piro O, Broze GJ Jr. Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding. Circulation. 2004;110(23):3567- 3572.
16. Lupu C, Goodwin CA, Westmuckett AD, et al. Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/ caveolae: regulatory mechanism(s) of the anticoagulant properties of the endothelium. Arterioscler Thromb Vasc Biol. 1997;17(11):2964-2974. (Pubitemid 28016049)
17. Zhang J, Piro O, Lu L, Broze, GJ Jr. Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor. Circulation. 2003;108(5):623- 627.
18. Broze GJ Jr, Miletich JP. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells. Proc Natl Acad Sci U S A. 1987;84(7):1886- 1890.
19. Novotny WF, Girard TJ, Miletich JP, Broze GJ Jr. Purification and characterization of the lipoprotein- associated coagulation inhibitor from human plasma. J Biol Chem. 1989;264(31):18832- 18837.
20. Sevinsky JR, Rao LV, Ruf W. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol. 1996;133(2):293-304. (Pubitemid 26131614)
21. Maroney SA, Cunningham AC, Ferrel J, et al. A GPI-anchored co-receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression. J Thromb Haemost. 2006;4(5):1114-1124.
22. Mast AE, Acharya N, Malecha MJ, Hall CL, Dietzen DJ. Characterization of the association of tissue factor pathway inhibitor with human placenta. Arterioscler Thromb Vasc Biol. 2002; 22(12):2099-2104. (Pubitemid 36025221)
23. Ott I, Miyagi Y, Miyazaki K, et al. Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol. 2000;20(3):874-882. (Pubitemid 30151706)
24. Broze GJ Jr, Lange GW, Duffin KL, MacPhail L. Heterogeneity of plasma tissue factor pathway inhibitor. Blood Coagul Fibrinolysis. 1994;5(4): 551-559. (Pubitemid 24301576)
25. Heffelfinger SC, Hawkins HH, Barrish J, Taylor BL, Darlington GJ. SK HEP-1: a human cell line of endothelial origin. In Vitro Cell Dev Biol. 1992;28A(2):136- 142.
26. Maroney SA, Ferrel JP, Pan S, et al. Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice. J Thromb Haemost. 2009;7(7):1106-1113.
27. Jaffe AE. Cell biology of endothelial cells. Hum Pathol. 1987;18(3):234-239.
28. Davy KP, Seals DR. Total blood volume in healthy young and older men. J Appl Physiol. 1994;76(5): 2059-2062. (Pubitemid 24158637)
29. Lupu C, Lupu F, Dennehy U, Kakkar VV, Scully MF. Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Arterioscler Thromb Vasc Biol. 1995;15(11):2055- 2062.
30. Ahamed J, Belting M, Ruf W. Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1. Blood. 2005;105(6):2384-2391. (Pubitemid 40387035)